SCHEMBL26115602

SCHEMBL26115602

CCCCCCCC/C=C\CCCCCCCC(=O)NC(CO)C(O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DEGS1 O15121 1/20 0.63
▸ ALDH1A1 P00352 1/20 0.62
▸ ASAH1 Q13510 1/20 0.62
▸ ACER2 Q5QJU3 1/20 0.62
▸ CETP P11597 3/20 0.62
▸ MEN1 O00255 3/20 0.61
▸ KMT2A Q03164 3/20 0.61
▸ THRB P10828 1/20 0.61
▸ UGCG Q16739 2/20 0.61
▸ SMPD2 O60906 1/20 0.59
▸ SMPD1 P17405 1/20 0.59
▸ TP53 P04637 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ CYP2D6 P10635 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ NFKB1 P19838 1/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ MAPT P10636 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26115606 1.00 DEGS1 (0.63) DEGS1ALDH1A1ASAH1ACER2CETP
SCHEMBL8341808 0.93 ALDH1A1 (0.71) DEGS1ALDH1A1ASAH1ACER2MEN1
SCHEMBL7773484 0.93 ALDH1A1 (0.71) DEGS1ALDH1A1ASAH1ACER2MEN1
SCHEMBL7773486 0.93 ALDH1A1 (0.71) DEGS1ALDH1A1ASAH1ACER2MEN1
SCHEMBL12435699 0.86 ASAH1 (0.85) ALDH1A1ASAH1ACER2UGCGCERT1
SCHEMBL19328599 0.85 ASAH2 (0.58) DEGS1ALDH1A1CETPMEN1KMT2A
SCHEMBL19352897 0.85 ASAH2 (0.58) DEGS1ALDH1A1CETPMEN1KMT2A
SCHEMBL19342491 0.85 ASAH2 (0.58) DEGS1ALDH1A1CETPMEN1KMT2A
SCHEMBL19342489 0.85 ASAH2 (0.58) DEGS1ALDH1A1CETPMEN1KMT2A
SCHEMBL19352747 0.84 ASAH2 (0.57) DEGS1ALDH1A1CETPMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250230125-A1 Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-07-17 — — US disclosed
EP-4504164-A1 SMALL MOLECULE ALLOSTERIC MODULATORS OF THE SEROTONIN (5-HT) 5-HT2C AND 5-HT2A RECEPTORS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-02-12 — — EP disclosed
WO-2023191951-A1 SMALL MOLECULE ALLOSTERIC MODULATORS OF THE SEROTONIN (5-HT) 5-HT2C AND 5-HT2A RECEPTORS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230125-A1 Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors HTR2C, HTR2A, HTR5A DEGS1 2238/4885ALDH1A1 3449/4885ASAH1 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback